RecruitingNCT07122128

EVALUATION OF SALIVA AS LIQUID BIOPSY FOR EARLY DETECTION OF ORAL CANCER IN PATIENTS WITH ORAL-SUBMUCOUS FIBROSIS (OSMF)

Saliva as Early Detection Tool for Oral Cancer


Sponsor

Liaquat University of Medical & Health Sciences

Enrollment

1,000 participants

Start Date

Jun 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Oral cancer is the top cancer in Pakistan, accounting for 27%, and it has a high mortality rate due to late-stage diagnosis. It primarily affects the lips, tongue, cheeks, and floor of the mouth. Major risk factor for oral cancer development is pan supari chhaliya chewing. Patients often develop a pre-malignant condition, oral submucous fibrosis, resulting in limited mouth opening. Thus, patients are diagnosed at an advanced level and poor survival. Therefore, saliva appears a potential mode of evaluation for early detection. This project aims to evaluate salivary cells, genes and biochemistry of the saliva among health volunteers and compare it with that of the patients with oral submucous fibrosis and oral cancer.


Eligibility

Inclusion Criteria3

  • healthy volunteers
  • patients with oral submucous fibrosis
  • patients with biopsy proven oral cancer

Exclusion Criteria1

  • patients with oral infection

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTsaliva a a diagnostic tool for early detection of oral cancer

Three groups will be compared on the basis of cytology, genes and biochemical analysis


Locations(1)

Medical Research Center

Jāmshoro, Sinch, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07122128